Above all, I genuinely believe that NMP cares about the team and the company’s success. It’s not just about the return we generate. I can’t overstate how much that trust matters.
CEO SPOTLIGHTS
We partner with strong CEOs of high-growth businesses, and together we scale.
If I started another company, NMP is the first investor I would call.
NMP has added tremendous value beyond capital. They helped us put together a board of operators with $1B+ exits, guided us on our transition from services to SaaS, and supported us through the pandemic.
A lot of firms focused on the “buzz” while Noro-Moseley was focused on developing a sustainable economic model and a scalable, successful business.
Our Exits
Our exits represent over $4 billion in aggregate enterprise value since 2015
NMP Investment Criteria
We are actively investing in businesses that meet these key criteria
-
Year-over-year growth
50%+
-
Compelling unit economics
-
Target revenue run rate
$2M-20M
-
nmp target investment
$5-20m
-
SIGNIFICANT OPPORTUNITY FOR MARKET DISRUPTION
-
Minimal prior funding
< $20M
NMP Portfolio News
view all news-
April 16, 2025
Liminal Raises $ 8.5M Series A to Build the Intelligence Platform for Complex Markets and Regulated Industries
-
December 12, 2024
Red Canary Delivers Record Q3, Maintaining Customer-Validated 99% Threat Accuracy at Scale
-
August 13, 2024
Upward Health Ranks No. 6 on the 2024 Inc. 5000
-
August 2, 2024
SPS Commerce Acquires SupplyPike
-
July 25, 2024
QuVa Pharma Completes Acquisition of LogicStream Health
-
July 17, 2024
AutoScheduler.ai Secures $ 6.5M Funding from Noro-Moseley Partners